J&J, Medivir's Olysio tested in all-oral HCV trial with Idenix drug
This article was originally published in Scrip
Executive Summary
Johnson & Johnson is testing its newly approved drug Olysio with Idenix Pharmaceuticals’ experimental therapy samatasvir in an all-oral hepatitis C study.